Home
Levena Biopharma Co.

Levena Biopharma Co. Market Share Analysis for July 2026

Industry: N/A

Domainlevenabiopharma.com

Year Founded2013

Employees51 - 200

Annual Revenue$5M - $10M

Levena Biopharma Co.

Levena Biopharma Co. (including company regionals)

levenabiopharma.com

See more website traffic and engagement information

Levena Biopharma Co. Revenue up to July 2026 is 5M - 10M

revenue generated by Levena Biopharma Co. top domains

Levena Biopharma Co. top domains revenue over 3 years

Revenue for Levena Biopharma Co. top domains

levenabiopharma.com5M - 10M

See more with Sales Intelligence

Total visits to Levena Biopharma Co.'s top domains

Understand Levena Biopharma Co. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

levenabiopharma.com1.3K

See more with Sales Intelligence

Avg. visit duration in Levena Biopharma Co.'s top domains

Analyze Levena Biopharma Co. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

levenabiopharma.com00:01:03

See more with Sales Intelligence

Avg. pageviews on Levena Biopharma Co.'s top domains

See how Levena Biopharma Co. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

levenabiopharma.com2.31

See more with Sales Intelligence

Levena Biopharma Co. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Levena Biopharma Co.

These are the website technologies, by industry, used by Levena Biopharma Co. top domains

Conversion & Analytics (3)

Google Analytics

eCommerce (2)

Swap

Email Services (2)

G Suite

Payment & Currencies (2)

Cart Functionality

More Technologies

7

See all

News & Signals from Levena Biopharma Co.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLevena Biopharma is developing ADCs targeting humoral immuno-suppressed cancers.Navrogen, a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, and Levena Biopharma, a company specialized in developing antibody drug conjugates (ADCs), have expanded their collaboration to develop ADCs targeting humoral immuno-suppressed cancers.